| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chagas disease.
|
Lancet
|
2010
|
10.25
|
|
2
|
Development and validation of a risk score for predicting death in Chagas' heart disease.
|
N Engl J Med
|
2006
|
6.00
|
|
3
|
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
|
N Engl J Med
|
2015
|
5.31
|
|
4
|
Evaluation and treatment of chagas disease in the United States: a systematic review.
|
JAMA
|
2007
|
5.22
|
|
5
|
American trypanosomiasis (Chagas disease).
|
Infect Dis Clin North Am
|
2012
|
2.04
|
|
6
|
Predictors of mortality in chronic Chagas disease: a systematic review of observational studies.
|
Circulation
|
2007
|
1.99
|
|
7
|
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
|
Am Heart J
|
2008
|
1.99
|
|
8
|
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.
|
Mem Inst Oswaldo Cruz
|
2009
|
1.54
|
|
9
|
Should tissue Doppler echocardiography be used to improve prediction of mortality risk in patients with Chagas cardiomyopathy?
|
Int J Cardiol
|
2011
|
1.38
|
|
10
|
Cardiac involvement with parasitic infections.
|
Clin Microbiol Rev
|
2010
|
1.32
|
|
11
|
Another disappointing result with implantable cardioverter-defibrillator therapy in patients with Chagas disease.
|
Europace
|
2013
|
1.08
|
|
12
|
[Guidelines for the evaluation and treatment of patients with cardiac arrhythmias].
|
Arq Bras Cardiol
|
2003
|
1.06
|
|
13
|
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.
|
Mem Inst Oswaldo Cruz
|
2009
|
1.05
|
|
14
|
Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.
|
PLoS Negl Trop Dis
|
2012
|
1.03
|
|
15
|
Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial.
|
Circulation
|
2012
|
0.98
|
|
16
|
Posaconazole versus benznidazole for chronic Chagas' disease.
|
N Engl J Med
|
2014
|
0.98
|
|
17
|
Infection by Trypanosoma cruzi metacyclic forms deficient in gp82 but expressing a related surface molecule, gp30.
|
Infect Immun
|
2003
|
0.98
|
|
18
|
Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected mice.
|
Microbes Infect
|
2005
|
0.98
|
|
19
|
Letter by Rassi and Rassi regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors".
|
Circulation
|
2013
|
0.97
|
|
20
|
Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.
|
Parasitol Res
|
2006
|
0.93
|
|
21
|
Update on Chagas heart disease on the first centenary of its discovery.
|
Rev Esp Cardiol
|
2009
|
0.92
|
|
22
|
Involvement of Ssp-4-related carbohydrate epitopes in mammalian cell invasion by Trypanosoma cruzi amastigotes.
|
Microbes Infect
|
2006
|
0.91
|
|
23
|
Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.
|
J Immunol Methods
|
2006
|
0.89
|
|
24
|
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
|
Am J Cardiol
|
2012
|
0.87
|
|
25
|
Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease.
|
Am J Trop Med Hyg
|
2007
|
0.84
|
|
26
|
Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease.
|
J Immunol Methods
|
2011
|
0.82
|
|
27
|
[Congenital transmission of Trypanosoma cruzi in Brazil: estimation of prevalence based on preliminary data of national serological surveys in children under 5 years old and other sources].
|
Rev Soc Bras Med Trop
|
2005
|
0.82
|
|
28
|
Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease.
|
Clin Diagn Lab Immunol
|
2002
|
0.82
|
|
29
|
[Correlation among the positivity of the artificial xenodiagnosis and the amount of blood and triatomines used in the exam, in chronic chagasic patients].
|
Rev Soc Bras Med Trop
|
2002
|
0.81
|
|
30
|
CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.
|
Am Heart J
|
2013
|
0.81
|
|
31
|
Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
|
J Cardiovasc Electrophysiol
|
2007
|
0.77
|
|
32
|
[Optimization of the medical treatment in coronary artery disease: a task for the subspecialist?].
|
Arq Bras Cardiol
|
2004
|
0.77
|
|
33
|
A Latin American man with palpitations, dizziness, episodes of nonsustained ventricular tachycardia, and an apical aneurysm.
|
PLoS Negl Trop Dis
|
2011
|
0.76
|
|
34
|
Letter by Rassi et al regarding article, "Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial".
|
Circ Heart Fail
|
2010
|
0.75
|
|
35
|
The art of risk stratification in Chagas' disease.
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
36
|
Prognostic utility of coronary computed tomography angiography: are we looking at the correct outcomes and making appropriate comparisons?
|
JACC Cardiovasc Imaging
|
2009
|
0.75
|
|
37
|
[Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease].
|
Rev Soc Bras Med Trop
|
2006
|
0.75
|
|
38
|
Is reclassification of intermediate-risk subjects by coronary artery calcium scoring clinically useful?
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
39
|
Case 2-2010: a man with abdominal and flank pain.
|
N Engl J Med
|
2010
|
0.75
|
|
40
|
Predicting prognosis in patients with Chagas disease: why are the results of various studies so different?
|
Int J Cardiol
|
2009
|
0.75
|
|
41
|
Preventing type 2 diabetes mellitus with angiotensin blockade: is it clinically relevant?
|
J Am Coll Cardiol
|
2006
|
0.75
|
|
42
|
Economic analysis of drug-eluting coronary stents in Brazil: a choice for all or just for a few patients?
|
Arq Bras Cardiol
|
2007
|
0.75
|
|
43
|
[Cardiovascular magnetic resonance and computed tomography imaging guidelines of the Brazilian Society of Cardiology].
|
Arq Bras Cardiol
|
2006
|
0.75
|